<DOC>
	<DOCNO>NCT01388361</DOCNO>
	<brief_summary>This trial conduct Europe North America . The aim trial compare efficacy safety add liraglutide versus addition insulin aspart large meal insulin degludec subject type 2 diabetes . Eligible subject HbA1c equal 7 % end treatment NN1250-3643 ( NCT01193309 ) trial randomise receive treatment intensification subject HbA1c 7 % end treatment NN1250-3643 ( NCT01193309 ) may continue receive insulin degludec treatment . Subjects continue pre-trial metformin treatment .</brief_summary>
	<brief_title>Comparison Efficacy Safety Two Intensification Strategies Subjects With Type 2 Diabetes Inadequately Controlled Basal Insulin Metformin</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<mesh_term>Insulin , Long-Acting</mesh_term>
	<mesh_term>Insulin Aspart</mesh_term>
	<mesh_term>Liraglutide</mesh_term>
	<criteria>Informed consent obtain trialrelated activity . ( Trialrelated activity procedure would perform normal management subject ) . The subject must complete end treatment visit NN12503643 Insulin degludec daily + metformin . Ability willingness adhere protocol include self measurement plasma glucose accord protocol Participated NN12503643 treat insulin glargine Previous treatment glucacon like peptide ( GLP1 ) receptor agonist ( e.g . exenatide , liraglutide ) Impaired liver function , define alanine aminotransferase ( ALAT ) 2.5 time upper limit normal end treatment NN12503643 Impaired renal function define serumcreatinine = 125 µmol/l ( = 1.4 mg/dl ) males = 110 µmol/L ( = 1.3 mg/dl ) females accord local label metformin [ For France : glomerular filtration rate 60 ml/min , calculate Cockroft &amp; Gault formula ] end treatment NN12503643 .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>